ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,134.80
0.66%
Dow Jones
40,287.53
-0.93%
Brent Oil
81.745
-0.65%
Bitcoin
67,400.04
-1.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fennec Pharmaceuticals Inc (FENC)

  7. Fennec Pharmaceuticals Inc (FENC) News

FENC

Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FENC
DateTimeSourceHeadlineSymbolCompany
07/01/20246:00AMGlobeNewswire Inc.Fennec Pharmaceuticals Announces Management ChangeNASDAQ:FENCFennec Pharmaceuticals Inc
06/25/20244:35PMGlobeNewswire Inc.Fennec Announces Results of Annual MeetingNASDAQ:FENCFennec Pharmaceuticals Inc
06/03/20246:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
06/03/20245:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
06/03/20244:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
05/21/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
05/21/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
05/21/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
05/14/20245:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
05/14/20246:03AMGlobeNewswire Inc.Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
05/13/20244:42PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FENCFennec Pharmaceuticals Inc
05/07/20246:15PMGlobeNewswire Inc.Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
03/21/20246:00AMGlobeNewswire Inc.Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
03/19/20246:01AMGlobeNewswire Inc.Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
03/18/20243:00AMPR Newswire (US)Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
03/17/20249:00PMGlobeNewswire Inc.Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
03/06/20244:07PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FENCFennec Pharmaceuticals Inc
02/29/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FENCFennec Pharmaceuticals Inc
02/29/20247:04AMGlobeNewswire Inc.Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsNASDAQ:FENCFennec Pharmaceuticals Inc
02/14/202410:47AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FENCFennec Pharmaceuticals Inc
02/01/20245:55AMGlobeNewswire Inc.FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving CisplatinNASDAQ:FENCFennec Pharmaceuticals Inc
01/05/20245:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
01/05/20244:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
01/04/20244:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
12/29/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
12/28/20233:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
12/18/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FENCFennec Pharmaceuticals Inc
12/05/20235:55AMGlobeNewswire Inc.Fennec Announces Incremental $5 Million Investment from PetrichorNASDAQ:FENCFennec Pharmaceuticals Inc
11/16/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
11/09/20234:56PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FENCFennec Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:FENC

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
NSAV
Net Savings Link (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved